Fosun Health Revenue, Valuation, Funding & Investors

Fosun Health is valued at $1.5B as of May 2024, a 1.6x multiple on its last reported $913M revenue.

Last Fosun Health valuation

$1.5B

Secondary · May 2024

Fosun Health revenue

$913M

Secondary · May 2024

Key investors in Fosun Health

  • Foshan Chanxi City Investment

Fosun Health Overview

About Fosun Health

Fosun Health is a Shanghai-based medical technology company delivering one-stop health management services. It integrates online consultations, diagnostics, and offline hospitals specializing in cardiology, oncology, and rehabilitation. Fosun Health operates facilities in 20 Chinese cities and partners with international providers for telemedicine. The ecosystem combines Fosun Pharma products with digital health apps for chronic disease management.


Founded

2010

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2C

Revenue model

Services

Revenue

$913M (May 2024)

Valuation

$1.5B (May 2024)

Fosun Health Valuation

Fosun Health is currently valued at $1.5B, based on its secondary sale in May 2024.

The $42M round was led by Foshan Chanxi City Investment.

Fosun Health valuation by funding round

Fosun Health valuation by funding round
DateStageValuationRevenue Multiple
May 2024Secondary$1.5B1.6x

Fosun Health Revenue

Fosun Health's latest recorded revenue is $913M, as of its secondary sale in May 2024. At a $1.5B valuation, that implies a 1.6x revenue multiple.

Fosun Health revenue by funding round

Fosun Health revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
May 2024$913M$1.5B1.6xSecondary

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Fosun Health Funding History

Fosun Health has 1 recorded secondary share sale and no primary funding rounds.

Fosun Health funding rounds

Fosun Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
May 2024SecondaryFoshan Chanxi City Investment (lead)$42M$1.5BShanghai Fosun Health Technology Group Co. Ltd., the hospital business unit of Shanghai Fosun Pharmaceutical, operates 18 medical facilities and holds eight internet hospital licenses. On May 14, 2024, it sold a 2.86% equity stake to Foshan Chanxi City Investment, a firm controlled by the Chancheng district government in Foshan city, for 300 million yuan, valuing the company at 10.2 billion yuan. Fosun Health committed to launching an IPO within five years, with a buyback clause if performance targets are unmet. The transaction dilutes Fosun Pharma's stake in Fosun Health to 97.1% from 100%. Proceeds will support daily operations, business development, and healthcare services consolidation. In 2023, Fosun Health reported revenue of 6.3 billion yuan but incurred a net loss of 420 million yuan.

Who has invested in Fosun Health?

1 investor has backed Fosun Health across its funding rounds, including Foshan Chanxi City Investment.

Lead investors include Foshan Chanxi City Investment.


Fosun Health Investors

Investors in Fosun Health by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 1 Fosun Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Fosun Health Competitors

Fosun Health competitors include listed companies like Nutex Health, Agilon Health, Siloam Hospitals and Ardent Health, and private ones like Metro Pacific Hospital Holdings and Kerala Institute of Medical Sciences.

Public and private companies comparable to Fosun Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Nutex HealthUnited StatesUnited StatesPublicly listed$875M$288M$1.5B2.0x
Agilon HealthUnited StatesUnited StatesPublicly listed$5.9B($369M)$1.5B0.2x
Siloam HospitalsIndonesiaIndonesiaPublicly listed$724M$161M$1.5B2.1x
Ardent HealthUnited StatesUnited StatesPublicly listed$6.3B$497M$1.5B0.5x
Metro Pacific Hospital HoldingsPhilippinesManilaPrivate--$1.6B-
Kerala Institute of Medical SciencesIndiaIndiaPrivate$118M-$1.3B10.6x

Fosun Health Public Comps

Fosun Health is still privately-owned, but its public comps include Nutex Health, Siloam Hospitals, Agilon Health, Ardent Health, National Medical Care, Aevis Victoria, Pennant Group, Ramsay Santé, Almoosa Health and Mitra Keluarga.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Nutex Health$875M$288M2.0x2.0x6.0x6.4x
Siloam Hospitals$724M$161M2.1x2.1x9.6x8.3x
Agilon Health$5.9B($369M)0.2x0.2x(3.6x)(57.2x)
Ardent Health$6.3B$497M0.5x0.5x6.9x6.7x
National Medical Care$427M$124M3.7x3.5x12.7x12.7x
Aevis Victoria$1.5B$101M1.2x1.3x17.9x15.2x
Pennant Group$948M$61M2.0x1.7x31.6x21.5x
Ramsay Santé$6.2B$720M0.9x-8.0x-

This data is available for Pro users. Sign up to see all Fosun Health competitors and their valuation data.

Start Free Trial

Common questions about Fosun Health

When was Fosun Health founded?Fosun Health was founded in 2010.
Where is Fosun Health headquartered?Fosun Health is headquartered in Shanghai, China.
Is Fosun Health publicly listed?No, Fosun Health is a private, VC-backed company.
What is Fosun Health's valuation?Fosun Health was last valued at $1.5B in its secondary sale in May 2024.
Who are Fosun Health's investors?Fosun Health's investors include Foshan Chanxi City Investment.
What is Fosun Health's revenue?Fosun Health's latest recorded revenue is $913M (May 2024).
What is Fosun Health's revenue multiple?Fosun Health's latest valuation implies a 1.6x revenue multiple ($1.5B valuation on $913M of revenue).
Which companies are comparable to Fosun Health?Companies comparable to Fosun Health include Nutex Health, Agilon Health, Siloam Hospitals, Ardent Health, Metro Pacific Hospital Holdings and Kerala Institute of Medical Sciences.

See companies similar to Fosun Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial